Since 1988, we have isolated HIV-1 from 614 HIV-1-infected persons (total sample =2,785) in Japan. During the past 12 years, we have found a decline in the HIV-1 isolation rate in Japan, with two identifiable turning points, 1991-1992 and 1996-1997. The two turning points correspond to shifts in anti-HIV-1 therapy. These findings suggest that HIV-1 in Japan is currently biologically well controlled, probably due to anti-HIV-1 therapy. On the other hand, this decline is inconsistent with the recent increase of genetic drugresistant HIV-1 in Japan. Further studies are needed to clarify mechanisms that might explain the discrepancy.Key words: HIV-1, Virus isolation, JapanSince 1988, we have isolated HIV-1 from a number of HIV-1-infected persons (n = 614, sample= 2,785) in Japan (4, 11). Most subjects are hemophiliacs (n= 307, sample = 1,962) who had repeatedly received intravenously administered infected blood products. The number of subjects infected by sexual transmission (n =-128, sample =532) is increasing steadily year by year, though subjects infected by vertical transmission (n= 14, sample = 14) are highly uncommon in this population. The study subjects include those with unknown transmission route (n = 165, sample = 277), although most of these infections are suspected to have been the result of sexual transmission. Profiles of the subjects are summarized in Table 1. The AIDS Surveillance Committee in Japan reported 4,838 HIV-1-infected individuals in Japan for the year 1999. Among the 4,838, 1,434 (30%) were hemophiliacs, 2,486 (51%) were infected by sexual transmission, 22 (0.5%) by vertical transmission, 22 (0.5%) were intravenous drug users, and 874 (18%) had an unknown transmission route. Compared with the group of all Japanese HIV-1 patients, our subjects are characterized by a predominance of hemophiliacs and vertical transmission.Isolation of the virus from both plasma (or serum) and peripheral blood mononuclear cells (PBMC) of the subjects was carried out based on a phytohemagglutinin (PHA)-stimulated PBMC cocultivation system, as recommended by Hollinger et al (3). In brief, plasma or PBMC were cocultivated with PHA-stimulated PBMC from an HIV-1-seronegative individual in RPMI-1640 containing 15% fetal calf serum, 50 U/ml of penicillin, 50After 7 days of culturing, the medium was changed and additional PHA-stimulated PBMC was fed. Cocultivation was maintained for more than 2 weeks. Isolated